Corporate News Report
Market Performance of Change Agents (CHGA)
- 24‑hour change: Change Agents (CHGA) increased by 15.71 % during the 24‑hour period ending at 01:09 PM Central Europe on Thursday, 22 October 2026.
- Current price: The share is trading at approximately USD 1.62 on major exchanges.
- Shares outstanding: The current supply of Change Agents stocks is 1.1 million.
- Market capitalization: The company has a market capitalization of USD 1.8 million.
- Volume: About USD 237.5 thousand worth of Change Agents shares were traded in the last 24 hours.
- Monthly trend: Since the end of the previous month, Change Agents has declined by 21.74 %.
- Technical indicators:
- 200‑day simple moving average: USD 8.54
- 52‑week high: USD 44.80 (recorded on 24 October 2025)
- 52‑week low: USD 1.33 (recorded on 20 October 2026)
Comparative Performance of Related Stocks (Past 24 Hours)
| Symbol | 24‑hour change | Current price (USD) | Market cap (USD) |
|---|---|---|---|
| NUWE (Nuwellis) | –5.45 % | 0.52 | 2 million |
| BRTX (Biorestorative Therapies) | –1.92 % | 1.53 | 2.1 million |
| KAPA (Kairos Pharma) | –1.20 % | 0.58 | 2 million |
| GOVX (Geovax Labs) | +2.20 % | 0.23 | 2.1 million |
| REVB (Revelation Biosciences) | –4.00 % | 3.60 | 2.1 million |
Revelation Biosciences (REVB) Investor Update
Revelation Biosciences has announced a live investor presentation to discuss recent financial results. The event, scheduled for late October, will allow shareholders to interact directly with senior management, including the chief executive officer and chief financial officer. The company will address performance metrics and strategic initiatives and encourages participants to submit questions before or during the session. The presentation is open to all existing and prospective investors, underscoring the company’s commitment to transparency and ongoing stakeholder engagement.
Company Overview – Avalon GloboCare Corp. (CHGA)
Avalon GloboCare Corp. is a biotechnology development and healthcare service provider headquartered in Freehold, United States. The company focuses on the development of diagnostic and therapeutic products, including oral cancer detection, skin regeneration, and fibrosis reduction. Avalon GloboCare serves a global client base and maintains a corporate website at www.avalon-globocare.com . The stock is listed on the Nasdaq exchange.